Related Experiment Video
Updated: Aug 9, 2026
08:54
In Vivo Assessment of Alveolar Macrophage Efferocytosis Following Ozone Exposure
Published on: October 22, 2019
Decreased alveolar oxygen induces lung inflammation
C Madjdpour1, U R Jewell, S Kneller
1Institute of Physiology, Department of Surgery, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland.
Summary
Alveolar hypoxia triggers lung inflammation by increasing macrophages and albumin leakage. Macrophages are crucial for this response, driving the expression of key inflammatory mediators in hypoxia-induced lung injury.
Area of Science:
- Pulmonary Medicine
- Inflammation Research
- Molecular Biology
Background:
- The molecular mechanisms of inflammation in hypoxia-induced lung injury remain poorly understood.
- Alveolar hypoxia is a significant factor in lung injury, but its precise cellular and molecular effects are not fully elucidated.
Purpose of the Study:
- To investigate the molecular mechanisms of the inflammatory response in rat lungs subjected to alveolar hypoxia.
- To determine the role of alveolar macrophages in hypoxia-induced lung inflammation and mediator expression.
Main Methods:
- Rats were exposed to 10% oxygen for varying durations (1-8 hours).
- Analysis included bronchoalveolar lavage fluid, albumin extravasation, and gene/protein expression (NF-kappaB, TNF-alpha, MIP-1beta, MCP-1, HIF-1alpha, ICAM-1).
- Alveolar macrophages were depleted using liposome-encapsulated clodronate to assess their role.
Main Results:
- Hypoxia increased macrophage recruitment and albumin extravasation in the lungs.
- Expression of inflammatory mediators (NF-kappaB, TNF-alpha, MIP-1beta, MCP-1) and hypoxia markers (HIF-1alpha, ICAM-1) were upregulated within hours of hypoxic exposure.
- Macrophage depletion significantly reduced the expression of these inflammatory markers.
Conclusions:
- Alveolar hypoxia initiates a significant inflammatory response in the lungs, characterized by macrophage influx and increased vascular permeability.
- Alveolar macrophages play a central role in mediating this inflammatory response and the subsequent upregulation of key inflammatory mediators.
- Targeting alveolar macrophages may offer a therapeutic strategy for hypoxia-induced lung injury.
Related Concept Videos
01:21Acute Respiratory Failure-II
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:10Atelectasis II: Pathophysiology
Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...